Gilead Science (GILD) Followers | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Gilead Science (GILD) Followers

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
961	87	0	GILD

Emcee: SybilNicolas	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
286	GILD mentioned on CNBC this morning: Gilead: FDA Says Data Insufficient For Fo	Henry Niman	-	5/7/1997
285	Yes indeed. It is not completely fair to bang on them for having lower Vistide	Skywatcher	-	5/1/1997
284	Chris, $50 million more in the bank. The stock purchase ($40 million) is to ha	Rick Strange	-	5/1/1997
283	This certainly should boost stock price. With the lastquarter having a smaller	Skywatcher	-	5/1/1997
282	Gilead's Vistide gets EU marketing authorization. This authorization allow	Rick Strange	-	5/1/1997
281	There you go! Go Vistide, Go! Doug	Doug Meetmer	-	4/29/1997
280	glurg..... uh....... hmmmm....... uh....... Well, maybe I should "wait a	scaram(o)uche	-	4/29/1997
279	This is not the latest info but I thought it might be of interest: Community A	T. Mann	-	4/29/1997
278	John: some of the stuff they presented last week included direct viral counts f	phbolton	-	4/28/1997
277	Phil, there's more to the efficacy story of DMP-266 than "4 to 5 log&q	John Metcalf	-	4/28/1997
276	Merck-DuPont's DMP-266 looks like a real winner of an anti-HIV drug. It is	phbolton	-	4/28/1997
275	CMV occurs in only the most severely of immunosuppressed patients. The mechani	scaram(o)uche	-	4/28/1997
274	That may be true certainly for the longterm, but it still takes a lot to conver	Doug Meetmer	-	4/28/1997
273	Doug, These drug combinations can arrest the progression of HIV including the	Rick Strange	-	4/28/1997
272	Because CMV is a disease only of the immunocompromised. No HIV, no CMV (or ver	scaram(o)uche	-	4/28/1997
271	why did protease inhibitors limit vistide sales? Protease inhibitors are used	Doug Meetmer	-	4/28/1997
270	My prior post had a typo. The cash position number in the last paragraph should	Rick Strange	-	4/27/1997
269	There is no question that protease inhibitors have limited Visitide sales durin	Rick Strange	-	4/27/1997
268	Paul, while I wouldn't label it "competition", yes, as a friend o	scaram(o)uche	-	4/26/1997
267	Vistide's revenues fell to $3.034 million in 1997's first quarter from	Paul Getman	-	4/26/1997
266	EARNINGS: Friday April 25 9:44 AM EDT Gilead announces first quarter 1997 fin	Skywatcher	-	4/25/1997
265	Doug, As a patient takes the drug, a reservoir of the drug builds up within th	wsnob	-	4/19/1997
264	Well I thought it was good news, but back down to 23 again. Bios just don't	Skywatcher	-	4/18/1997
263	Been out of town, but did anyone post this? <b>90%</b> looking good	Skywatcher	-	4/15/1997
262	Do you mean that the prophylactic effect continues even after discontinuation o	Doug Meetmer	-	4/14/1997

Go to reply# or date (mm/dd/yy):